Digital tools like eCTD, RIMS, AI-powered pharmacovigilance, and electronic submissions are revolutionizing healthcare regulatory consultancy in the Middle East and GCC, enhancing compliance, safety, and market access.
Interactive workshop offers strategies for Middle East GCC regulatory readiness, covering SFDA, EDA, UAE MoHAP, eCTD dossier localization, pharmacovigilance, GMP/GDP, plus expert consultation and templates.
Middle East and GCC pharma regulations are rapidly evolving with digital submissions, stricter pharmacovigilance, biotech scrutiny, and tougher device registration, requiring strategic compliance and local expertise.
7 Emerging Trends in Middle Eastern and GCC Pharma Regulations to Watch Now Read More »
This guide explains GCC licensing, manufacturing, and compliance requirements, highlighting SFDA/MOHAP registration, Saudi GMP standards, and ISO 13485 for smoother market entry and regulatory success.
